Revolution Medicines (RVMDW) Q2 2026 Earnings

6MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-2.29
-1.89
-1.49
-1.09

Details

Expected EPS
-1.835687
Actual EPS
-2.29
Surprise EPS
-0.45
Surprise Percent
+24.75%

Description

Revolution Medicines (RVMDW) has reported earnings of -2.29 per share for Q2 2026.

0 Comments

Share your thoughts